Applying technologies towards safe and effective medicines.
نویسنده
چکیده
منابع مشابه
Towards safe and effective phytomedicines:the need for standardization
Over the past 20 years herbal medicinal products have become a topic of increasing global importance, with both medical and economic implications. In developing countries in Africa and Asia, botanicals have always played a central role in healthcare. Data from WHO suggest that 65 to 80% of the populations in these countries depend on traditional and botanical medicines as the primary source of ...
متن کاملTowards safe and effective phytomedicines:the need for standardization
Over the past 20 years herbal medicinal products have become a topic of increasing global importance, with both medical and economic implications. In developing countries in Africa and Asia, botanicals have always played a central role in healthcare. Data from WHO suggest that 65 to 80% of the populations in these countries depend on traditional and botanical medicines as the primary source of ...
متن کاملنقش حقوق رقابت در بهبود سلامت عمومی
Competition as an important incentive for innovation leads to freedom of choice and price reduction and contributes to more rapid provision of new and effective therapeutic technologies. On the other hand, anti-competitive practices adopted by economic undertakings in the health sector may disrupt competition including limited access to medicines and medical services or increase in their price....
متن کاملPharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference
In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference p...
متن کاملChallenges and opportunities for pharmaceutical pricing and reimbursement policies
Even though access to affordable medicines is a human right, it is not ensured world-wide. The Priority Medicines Report 2013 [1] identified pharmaceutical gaps that continue to remain: diseases of public health importance for which pharmaceutical treatments either do not exist or are inadequate (see also K4). Where adequate treatments were available, access might be limited due to high costs o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BioTechniques
دوره 39 10 Suppl شماره
صفحات -
تاریخ انتشار 2005